SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  

Davita Inc · 10-K · For 12/31/04 · EX-10.31

Filed On 3/2/05 9:48pm ET   ·   SEC File 1-14106   ·   Accession Number 1193125-5-41002

  in   Show  and 
  As Of               Filer                 Filing     As/For/On Docs:Pgs              Issuer               Agent

 3/03/05  Davita Inc                        10-K       12/31/04   15:280                                    1193125

Annual Report   ·   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10k for Davita, Inc.                           HTML    962K 
 2: EX-10.9     Amended and Restated Employment Agreement Between   HTML     75K 
                          Davita and Denise Fletcher                             
 3: EX-10.11    Employment Agreement, Effective as of Nov. 18,      HTML     78K 
                          2004                                                   
 4: EX-10.27    Amended and Restated Agreement Dated Dec. 2, 2004   HTML    683K 
 5: EX-10.28    Form of Indemnity Agreement                         HTML     55K 
 6: EX-10.30    Post-Retirement Deferred Compensation Agreement     HTML     63K 
 7: EX-10.31    Memorandum Relating to Bonus Structure for Charles  HTML     13K 
                          J. McAllister                                          
 8: EX-10.32    Director Compensation Philosophy and Plan           HTML     15K 
 9: EX-12.1     Computation of Ratios of Earnings to Fixed Charges  HTML     32K 
10: EX-21.1     List of Our Subsidiaries                            HTML     56K 
11: EX-23.1     Consent of Kpmg Llp                                 HTML     11K 
12: EX-31.1     Certification of Ceo Pursuant to Section 302        HTML     16K 
13: EX-31.2     Certification of Cfo Pursuant to Section 302        HTML     16K 
14: EX-32.1     Certification of Ceo Pursuant to Section 906        HTML     11K 
15: EX-32.2     Certification of Cfo Pursuant to Section 906        HTML     11K 


EX-10.31   ·   Memorandum Relating to Bonus Structure for Charles J. McAllister


This is an EDGAR HTML document rendered as filed.  [ Alternative Formats ]


  Memorandum relating to bonus structure for Charles J. McAllister  

Exhibit 10.31

 

Memorandum Relating to Bonus Structure for

 

Charles J. McAllister

 

1. Bonus:

 

  a. OIG sets drug acquisition costs that accurately reflect industry acquisition costs -$100,000 (30% displacement)

 

  b. CMS implements MMA 2003 payment changes in a way that has a revenue neutral effect on DaVita—$100,000 (zero displacement)

 

  c. The CMS EPO coverage rules currently contemplated by CMS, and which are expected to be released in 2004, do not negatively impact clinical practices for EPO, either because:

 

  I. CMS establishes an EPO NCD that is substantially consistent with current clinical protocols; or

 

  II. CMS maintains current policy (either by taking no action or by delaying implementation of an EPO NCD)

 

  - $200,000 (30% displacement).

 

  d. Set up quality, general meeting for DaVita CEO with                      ($10,000, 50% displacement).

 

  e. Set up quality, general meeting for DaVita CEO with                      ($20,000, 50% displacement).

 

2. Timing:

 

  a. The bonuses associated with a goal will be paid as soon as it is clear that the particular goal is met.

 

  b. Payment may be within calendar year 2004 or after.

 

3. Displacement example: A 30% displacement means that if a $100,000 touchdown bonus is paid, the normal bonus range is reduced by $30,000. This is to reflect that the area being rewarded was a part of the normal job, but it is receiving special emphasis.

 

4. The DaVita CEO has full authority to exercise reasonable discretion if the bonus has been earned. If something changes to make the task much easier or far less valuable the CEO has the right and responsibility to adjust or eliminate it. If the Executive disagrees he/she can appeal Chair of the Compensation Committee of the Board of Directors.

Filing Submission   -   Alternative Formats (Word / Rich Text, HTML, Plain Text, SGML, XML, et al.)
Copyright © 2008 Fran Finnegan & Company  All Rights Reserved.
www.secinfo.com - Tue, 13 May 2008 00:02:36.1 GMT - Help at SEC Info